Adage Capital Partners’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Adage Capital Partners’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-819,160	Closed	-$49M	–	841
2020 Q2	$49M	Sell	819,160 -45,840	-5%	-$2.83M	0.13%	188
2020 Q1	$51.4M	Buy	865,000 +365,000	+73%	+$21.3M	0.15%	165
2019 Q4	$27.4M	Buy	500,000 +100,000	+25%	+$3.73M	0.07%	316
2019 Q3	$11.3M	Sell	400,000 -100,000	-20%	-$3.67M	0.03%	499
2019 Q2	$16.6M	Sell	500,000 -200,000	-29%	-$6.24M	0.04%	406
2019 Q1	$23.8M	Hold	700,000	–	–	0.06%	341
2018 Q4	$19.2M	Buy	700,000 +400,000	+133%	+$10.3M	0.05%	346
2018 Q3	$8.77M	Buy	+300,000	New	+$8.47M	0.02%	563

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Adage Capital Partners's PRNB Position: Q3 2020 in Review

Adage Capital Partners sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 819,160 shares — an estimated $49M sold.

Adage Capital Partners first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $51.4M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Adage Capital Partners reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Adage Capital Partners sold 819,160 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $49M.
Adage Capital Partners first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Adage Capital Partners's Principia Biopharma Inc. Common Stock position peaked at $51.4M in Q1 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.